Artivion Inc (AORT)vsGE HealthCare Technologies Inc. (GEHC)
AORT
Artivion Inc
$36.12
+1.18%
HEALTHCARE · Cap: $1.73B
GEHC
GE HealthCare Technologies Inc.
$72.20
+1.75%
HEALTHCARE · Cap: $32.38B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 4573% more annual revenue ($20.63B vs $441.33M). GEHC leads profitability with a 10.1% profit margin vs 2.2%. GEHC appears more attractively valued with a PEG of 1.70. GEHC earns a higher WallStSmart Score of 60/100 (C+).
AORT
Hold39
out of 100
Grade: F
GEHC
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-2704.2%
Fair Value
$1.43
Current Price
$36.12
$34.69 premium
Margin of Safety
-156.0%
Fair Value
$30.94
Current Price
$72.20
$41.26 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
19.2% revenue growth
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 2.7% — below average capital efficiency
2.2% margin — thin
Expensive relative to growth rate
Weak financial health signals
Earnings declined 17.7%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AORT
The strongest argument for AORT centers on Revenue Growth. Revenue growth of 19.2% demonstrates continued momentum.
Bull Case : GEHC
The strongest argument for GEHC centers on Return on Equity, P/E Ratio.
Bear Case : AORT
The primary concerns for AORT are EPS Growth, Market Cap, Return on Equity. A P/E of 172.0x leaves little room for execution misses. Thin 2.2% margins leave little buffer for downturns.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
AORT profiles as a growth stock while GEHC is a value play — different risk/reward profiles.
AORT carries more volatility with a beta of 1.64 — expect wider price swings.
AORT is growing revenue faster at 19.2% — sustainability is the question.
GEHC generates stronger free cash flow (917M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (60/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Artivion Inc
HEALTHCARE · MEDICAL DEVICES · USA
Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?